Innate Immunity and CKD: Is There a Significant Association?

Area of Science:

• Nephrology
• Immunology
• Cardiovascular Medicine

Background:

• Chronic kidney disease (CKD) is a global epidemic impacting 10% of the population, leading to significant health and economic burdens.
• CKD patients experience high rates of morbidity and mortality, primarily due to cardiovascular events.
• Chronic inflammation is a central factor in CKD progression and exacerbates complications like atherosclerosis and cardiovascular disease (CVD).

Purpose of the Study:

• To review the role of the innate immune system in CKD pathogenesis.
• To examine the impact of chronic inflammation on CKD complications.
• To provide an overview of current therapeutic strategies for mitigating CKD-related inflammation.

Main Methods:

• Literature review of existing research on CKD, inflammation, and immune system involvement.
• Analysis of studies identifying activated innate immune components in CKD patients.
• Synthesis of data on current therapeutic approaches targeting CKD inflammation.

Main Results:

• Chronic inflammation is a significant component of the uremic phenotype in CKD.
• Inflammation accelerates CKD complications, including atherosclerosis, CVD, and protein-energy wasting, in both dialysis and pre-dialysis patients.
• Despite extensive research into immune system involvement, effective treatments remain limited.

Conclusions:

• The innate immune system plays a critical role in the inflammatory processes underlying CKD complications.
• Targeting chronic inflammation is crucial for managing CKD and its associated cardiovascular risks.
• Further research and development of targeted therapies are needed to effectively counteract CKD-related inflammation.